サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1370221

非侵襲的出生前検査市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Non-Invasive Prenatal Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 148 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
非侵襲的出生前検査市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年10月15日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

市場概要：

世界の非侵襲的出生前検査市場規模は2022年に34億米ドルに達しました。今後、IMARC Groupは、市場は2023年から2028年の間に17.2%の成長率（CAGR）を示し、2028年までに85億米ドルに達すると予測しています。

非侵襲的出生前検査（NIPT）は、胎児の異常の有無を検出するために妊婦の血液サンプルを用いて実施される出生前スクリーニングの一形態です。この検査は主に、母親の血液中のDNA断片を分析することにより、ダウン症候群（またはトリソミー21）、エドワーズ症候群（またはトリソミー18）、パタウ症候群（またはトリソミー13）、ターナー症候群などの遺伝性疾患を診断するために用いられます。この方法は、絨毛膜絨毛サンプリング（CVS）のような様々な不安定で侵襲的な処置の必要性をなくし、妊娠9週以降に実施することができます。

胎児の遺伝性疾患の有病率の増加は、市場成長を促進する主な要因の一つです。さらに、ライフサイエンスやヘルスケア産業分野での技術進歩も市場を後押ししています。例えば、DNAシークエンシング技術の開発、再生医療、分子研究における飛躍的な進歩は、あらゆる重篤な疾患の可能性を未熟な段階で克服する計り知れない可能性を生み出しています。さらに、出生前検査の受け入れ率の増加、健康意識の高まり、大衆の間でこのような検査の利点と意義に関する認識も、市場成長の原動力となっています。二分脊椎、口蓋裂、鎌状赤血球貧血を含む他の遺伝性疾患を診断し、胎児発育の初期段階で治療するための代替手段を、妊産婦だけでなくヘルスケア提供者も採用しています。さらに、母親の高年齢出産（35歳以上）への動向の変化も、市場成長にプラスの影響を与えています。母体年齢の上昇は、高血圧、生殖能力の低下、流産のリスク、胎児の染色体異常リスクの増加など、多くの健康合併症を引き起こす可能性があります。

本レポートで扱う主な質問

  • 2022年の世界の非侵襲的出生前検査市場規模は？
  • 2023～2028年の世界の非侵襲的出生前検査市場の予想成長率は？
  • 世界の非侵襲的出生前検査市場を牽引する主要因は何か？
  • COVID-19が世界の非侵襲的出生前検査市場に与えた影響は？
  • 非侵襲的出生前検査の世界市場における製品タイプ別の区分は？
  • 検査タイプに基づく非侵襲的出生前検査の世界市場の内訳は？
  • 技術に基づく非侵襲的出生前検査の世界市場の内訳は？
  • 方法に基づく非侵襲的出生前検査の世界市場の内訳は？
  • 用途に基づく非侵襲的出生前検査の世界市場の内訳は？
  • エンドユーザーに基づく世界の非侵襲的出生前検査市場の内訳は？
  • 世界の非侵襲的出生前検査市場の主要地域は？
  • 世界の非侵襲的出生前検査市場における主要企業/プレーヤーは？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 非侵襲的出生前検査の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • 消耗品
    • 市場動向
    • 市場予測
  • 楽器
    • 市場動向
    • 市場予測

第7章 市場内訳：検査タイプ別

  • マテルニ21
    • 市場動向
    • 市場予測
  • ハーモニー
    • 市場動向
    • 市場予測
  • パナロマ
    • 市場動向
    • 市場予測
  • ベリファイ
    • 市場動向
    • 市場予測
  • ニフティ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：技術別

  • NGS市場
    • 市場動向
    • 市場予測
  • WGS
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：検査方法別

  • 超音波検出
    • 市場動向
    • 市場予測
  • 生化学スクリーニング検査
    • 市場動向
    • 市場予測
  • 母体血漿中の無細胞DNA検査
    • 市場動向
    • 市場予測
  • 母体血液検査における胎児細胞
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：用途別

  • トリソミー
    • 市場動向
    • 市場予測
  • 微小欠失症候群
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第11章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 診断ラボ
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第12章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第13章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第14章 バリューチェーン分析

第15章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies, Inc.
    • Berry Genetics Inc.
    • BGI Genomics Co. Ltd.
    • Eurofins Scientific Services Limited
    • F. Hoffmann-La Roche Ltd
    • GE Healthcare
    • Igenomix
    • Illumina Inc.
    • Laboratory Corporation
    • Natera Inc.
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
    • Yourgene Health plc
図表

List of Figures

  • Figure 1: Global: Non-Invasive Prenatal Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Non-Invasive Prenatal Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Non-Invasive Prenatal Testing Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Non-Invasive Prenatal Testing Market: Breakup by Test Type (in %), 2022
  • Figure 5: Global: Non-Invasive Prenatal Testing Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Non-Invasive Prenatal Testing Market: Breakup by Method (in %), 2022
  • Figure 7: Global: Non-Invasive Prenatal Testing Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Non-Invasive Prenatal Testing Market: Breakup by End-User (in %), 2022
  • Figure 9: Global: Non-Invasive Prenatal Testing Market: Breakup by Region (in %), 2022
  • Figure 10: Global: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 11: Global: Non-Invasive Prenatal Testing (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Non-Invasive Prenatal Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Non-Invasive Prenatal Testing (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Non-Invasive Prenatal Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Non-Invasive Prenatal Testing (Materni 21) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Non-Invasive Prenatal Testing (Materni 21) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Non-Invasive Prenatal Testing (Harmony) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Non-Invasive Prenatal Testing (Harmony) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Non-Invasive Prenatal Testing (Panaroma) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Non-Invasive Prenatal Testing (Panaroma) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Non-Invasive Prenatal Testing (Verifi) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Non-Invasive Prenatal Testing (Verifi) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Non-Invasive Prenatal Testing (NIFTY) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Non-Invasive Prenatal Testing (NIFTY) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Non-Invasive Prenatal Testing (NGS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Non-Invasive Prenatal Testing (NGS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Non-Invasive Prenatal Testing (WGS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Non-Invasive Prenatal Testing (WGS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Non-Invasive Prenatal Testing (Trisomy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Non-Invasive Prenatal Testing (Trisomy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Global: Non-Invasive Prenatal Testing (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Global: Non-Invasive Prenatal Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: North America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: North America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: United States: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: United States: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Canada: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Canada: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Asia Pacific: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Asia Pacific: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: China: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: China: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Japan: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Japan: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: India: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: India: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: South Korea: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: South Korea: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Australia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Australia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Indonesia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Indonesia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Europe: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Europe: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Germany: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Germany: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: France: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: France: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: United Kingdom: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: United Kingdom: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Italy: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Italy: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Spain: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Spain: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Russia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Russia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 93: Latin America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 94: Latin America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Brazil: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 96: Brazil: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 97: Mexico: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 98: Mexico: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 99: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 100: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 101: Middle East and Africa: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 102: Middle East and Africa: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 103: Global: Non-Invasive Prenatal Testing Industry: SWOT Analysis
  • Figure 104: Global: Non-Invasive Prenatal Testing Industry: Value Chain Analysis
  • Figure 105: Global: Non-Invasive Prenatal Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Non-Invasive Prenatal Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 4: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 5: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Method (in Million US$), 2023-2028
  • Table 6: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 7: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by End-User (in Million US$), 2023-2028
  • Table 8: Global: Non-Invasive Prenatal Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 9: Global: Non-Invasive Prenatal Testing Market Structure
  • Table 10: Global: Non-Invasive Prenatal Testing Market: Key Players
目次
Product Code: SR112023A2086

Abstract

Market Overview:

The global non-invasive prenatal testing market size reached US$ 3.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.5 Billion by 2028, exhibiting a growth rate (CAGR) of 17.2% during 2023-2028.

Non-invasive prenatal testing (NIPT) is a form of prenatal screening conducted on a pregnant woman's blood sample to detect the presence of fetal abnormalities. The test is primarily used to diagnose genetic disorders such as Down syndrome (or trisomy 21), Edwards syndrome (or trisomy 18), Patau syndrome (or trisomy 13) and Turner syndrome, by analyzing DNA fragments in the mother's blood. The procedure eliminates the need for various precarious and invasive procedures, such as chorionic villus sampling (CVS) and can be performed after nine weeks of pregnancy.

The growing prevalence of genetic disorders of the fetus is one of the key factors driving the market growth. Furthermore, technological advancements in the field of life sciences and healthcare industry is also providing a boost to the market. For instance, the development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have created immense possibilities to combat the chances of any serious disease at the primitive stage itself. Additionally, the increasing acceptance rate for prenatal testing, along with rising health consciousness and awareness regarding the benefits and significance of such testing among the masses, is also driving the market growth. Healthcare providers, as well as expecting parents, are adopting alternatives to diagnose other genetic disorders, including spina bifida, cleft palate, and sickle cell anemia, and treat them in the early stages of fetal development. Moreover, the shifting trend toward childbearing at high maternal age (35 years or older) is also positively impacting the market growth. Advancing maternal age can lead to numerous health complications, such as high blood pressure, reduced fertility, risk of miscarriage and increased risk of chromosomal anomalies in the fetus.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global non-invasive prenatal testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, test type, technology, method, application and end-user.

Breakup by Product Type:

Consumables

Instruments

Breakup by Test Type:

Materni 21

Harmony

Panaroma

Verifi

NIFTY

Others

Breakup by Technology:

NGS

WGS

Others

Breakup by Method:

Ultrasound Detection

Biochemical Screening Tests

Cell-Free DNA in Maternal Plasma Tests

Fetal Cells in Maternal Blood Tests

Others

Breakup by Application:

Trisomy

Microdeletion Syndrome

Others

Breakup by End-User:

Hospitals

Diagnostic Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the top non invasive prenatal testing companies key players being Agilent Technologies, Inc., Berry Genetics, Inc., BGI Genomics Co., Ltd., Eurofins Scientific Services Limited, F. Hoffmann-La Roche Ltd, GE Healthcare, Igenomix, Illumina Inc., Laboratory Corporation, Natera Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., and Yourgene Health plc.

Key Questions Answered in This Report

  • 1. What was the size of the global non-invasive prenatal testing market in 2022?
  • 2. What is the expected growth rate of the global non-invasive prenatal testing market during 2023-2028?
  • 3. What are the key factors driving the global non-invasive prenatal testing market?
  • 4. What has been the impact of COVID-19 on the global non-invasive prenatal testing market
  • 5. What is the breakup of the global non-invasive prenatal testing market based on the product type?
  • 6. What is the breakup of the global non-invasive prenatal testing market based on the test type?
  • 7. What is the breakup of the global non-invasive prenatal testing market based on the technology?
  • 8. What is the breakup of the global non-invasive prenatal testing market based on the method?
  • 9. What is the breakup of the global non-invasive prenatal testing market based on the application?
  • 10. What is the breakup of the global non-invasive prenatal testing market based on the end-user?
  • 11. What are the key regions in the global non-invasive prenatal testing market?
  • 12. Who are the key companies/players in the global non-invasive prenatal testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Non-Invasive Prenatal Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Materni 21
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Harmony
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Panaroma
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Verifi
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 NIFTY
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 NGS
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 WGS
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Method

  • 9.1 Ultrasound Detection
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biochemical Screening Tests
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Cell-Free DNA in Maternal Plasma Tests
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Fetal Cells in Maternal Blood Tests
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Trisomy
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Microdeletion Syndrome
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by End-User

  • 11.1 Hospitals
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Diagnostic Laboratories
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Others
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast

12 Market Breakup by Region

  • 12.1 North America
    • 12.1.1 United States
      • 12.1.1.1 Market Trends
      • 12.1.1.2 Market Forecast
    • 12.1.2 Canada
      • 12.1.2.1 Market Trends
      • 12.1.2.2 Market Forecast
  • 12.2 Asia Pacific
    • 12.2.1 China
      • 12.2.1.1 Market Trends
      • 12.2.1.2 Market Forecast
    • 12.2.2 Japan
      • 12.2.2.1 Market Trends
      • 12.2.2.2 Market Forecast
    • 12.2.3 India
      • 12.2.3.1 Market Trends
      • 12.2.3.2 Market Forecast
    • 12.2.4 South Korea
      • 12.2.4.1 Market Trends
      • 12.2.4.2 Market Forecast
    • 12.2.5 Australia
      • 12.2.5.1 Market Trends
      • 12.2.5.2 Market Forecast
    • 12.2.6 Indonesia
      • 12.2.6.1 Market Trends
      • 12.2.6.2 Market Forecast
    • 12.2.7 Others
      • 12.2.7.1 Market Trends
      • 12.2.7.2 Market Forecast
  • 12.3 Europe
    • 12.3.1 Germany
      • 12.3.1.1 Market Trends
      • 12.3.1.2 Market Forecast
    • 12.3.2 France
      • 12.3.2.1 Market Trends
      • 12.3.2.2 Market Forecast
    • 12.3.3 United Kingdom
      • 12.3.3.1 Market Trends
      • 12.3.3.2 Market Forecast
    • 12.3.4 Italy
      • 12.3.4.1 Market Trends
      • 12.3.4.2 Market Forecast
    • 12.3.5 Spain
      • 12.3.5.1 Market Trends
      • 12.3.5.2 Market Forecast
    • 12.3.6 Russia
      • 12.3.6.1 Market Trends
      • 12.3.6.2 Market Forecast
    • 12.3.7 Others
      • 12.3.7.1 Market Trends
      • 12.3.7.2 Market Forecast
  • 12.4 Latin America
    • 12.4.1 Brazil
      • 12.4.1.1 Market Trends
      • 12.4.1.2 Market Forecast
    • 12.4.2 Mexico
      • 12.4.2.1 Market Trends
      • 12.4.2.2 Market Forecast
    • 12.4.3 Others
      • 12.4.3.1 Market Trends
      • 12.4.3.2 Market Forecast
  • 12.5 Middle East and Africa
    • 12.5.1 Market Trends
    • 12.5.2 Market Breakup by Country
    • 12.5.3 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porters Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies, Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Berry Genetics Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 BGI Genomics Co. Ltd.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
    • 16.3.4 Eurofins Scientific Services Limited
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
    • 16.3.5 F. Hoffmann-La Roche Ltd
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 SWOT Analysis
    • 16.3.6 GE Healthcare
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Igenomix
      • 16.3.7.1 Company. Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
    • 16.3.8 Illumina Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Laboratory Corporation
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Natera Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 Perkinelmer Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Thermo Fisher Scientific Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Yourgene Health plc
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials